{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T19:11:20Z","timestamp":1782587480988,"version":"3.54.5"},"reference-count":62,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2011,6,30]],"date-time":"2011-06-30T00:00:00Z","timestamp":1309392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0021685","type":"journal-article","created":{"date-parts":[[2011,6,30]],"date-time":"2011-06-30T20:58:38Z","timestamp":1309467518000},"page":"e21685","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":37,"title":["Proton Magnetic Resonance Spectroscopy in 22q11 Deletion Syndrome"],"prefix":"10.1371","volume":"6","author":[{"given":"Fabiana","family":"da Silva Alves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Boot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aart","family":"Nederveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Vorstman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Lavini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Pouwels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieuwe","family":"de Haan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don","family":"Linszen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"van Amelsvoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,6,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ddrr.9","article-title":"Genes, brain development and psychiatric phenotypes in velo-cardio-facial syndrome.","volume":"14","author":"D Gothelf","year":"2008","journal-title":"Dev Disabil Res Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1542\/peds.112.1.101","article-title":"A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population.","volume":"112","author":"LD Botto","year":"2003","journal-title":"Pediatrics"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/archpsyc.56.10.940","article-title":"High rates of schizophrenia in adults with velo-cardio-facial syndrome.","volume":"56","author":"KC Murphy","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.schres.2007.09.025","article-title":"Prevalence of 22q11.2 deletions in 311 Dutch patients with schizophrenia.","volume":"98","author":"ML Hoogendoorn","year":"2008","journal-title":"Schizophr Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature07239","article-title":"Rare chromosomal deletions and duplications increase risk of schizophrenia.","volume":"455","author":"LJ Stone","year":"2008","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/35098574","article-title":"Chromosomal microdeletions: dissecting del22q11 syndrome.","volume":"2","author":"EA Lindsay","year":"2001","journal-title":"Nat Rev Genet"},{"key":"ref7","first-page":"1821","article-title":"Disorders of proline and hydroxyproline metabolism","author":"JM Phang","year":"2001","journal-title":"Disorders of proline and hydroxyproline metabolism"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1086\/428142","article-title":"Functional consequences of PRODH missense mutations.","volume":"76","author":"HU Bender","year":"2005","journal-title":"Am J Hum Genet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1093\/hmg\/11.19.2243","article-title":"PRODH mutations and hyperprolinemia in a subset of schizophrenic patients.","volume":"11","author":"H Jacquet","year":"2002","journal-title":"Hum Mol Genet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1073\/pnas.042700699","article-title":"Genetic variation at the 22q11 PRODH2\/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia.","volume":"99","author":"H Lui","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/nn1562","article-title":"Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice.","volume":"8","author":"M Paterlini","year":"2005","journal-title":"Nat Neurosci"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/hmg\/ddl443","article-title":"Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome.","volume":"16","author":"G Raux","year":"2007","journal-title":"Hum Mol Genet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00726-008-0111-0","article-title":"PRODH variants and risk for schizophrenia.","volume":"35","author":"A Willis","year":"2008","journal-title":"Amino Acids"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0006-8993(97)00721-X","article-title":"Proline-induced inhibition of glutamate release in hippocampal area CA1.","volume":"769","author":"SM Cohen","year":"1997","journal-title":"Brain Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0006-8993(97)00352-1","article-title":"Proline-induced potentiation of glutamate transmission.","volume":"761","author":"SM Cohen","year":"1997","journal-title":"Brain Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.neuron.2006.09.023","article-title":"Modeling madness in mice: one piece at a time.","volume":"52","author":"PA Arguello","year":"2006","journal-title":"Neuron"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.","volume":"51","author":"JH Krystal","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0893-133X(94)00131-I","article-title":"Subanesthetic doses of ketamine stimulate psychosis in schizophrenia.","volume":"13","author":"AC Lahti","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00213-004-1792-z","article-title":"Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia.","volume":"174","author":"B Moghaddam","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/archpsyc.56.1.21","article-title":"A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia.","volume":"56","author":"DC Goff","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/sj.npp.1301312","article-title":"Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders.","volume":"32","author":"M Beneyto","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0278-5846(03)00078-2","article-title":"Glutamine synthetase and glutamate dehydrogenase in the prefrontal cortex of patients with schizophrenia.","volume":"27","author":"GS Burbaeva","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/sj.mp.4001558","article-title":"Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.","volume":"10","author":"PJ Harrison","year":"2005","journal-title":"Mol Psychiatry"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/sj.mp.4001751","article-title":"First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients.","volume":"11","author":"LS Pilowsky","year":"2006","journal-title":"Mol Psychiatry"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0022-3956(99)00029-1","article-title":"NMDA receptor hypofunction model of schizophrenia.","volume":"33","author":"JW Olney","year":"1999","journal-title":"J Psychiatr Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.crad.2008.07.002","article-title":"Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications.","volume":"64","author":"DP Soares","year":"2009","journal-title":"Clin Radiol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/archpsyc.1997.01830220085012","article-title":"Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy.","volume":"54","author":"R Bartha","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1176\/appi.ajp.159.11.1944","article-title":"Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers.","volume":"159","author":"J Theberge","year":"2002","journal-title":"Am J Psychiatry"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1176\/appi.ajp.160.12.2231","article-title":"Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS.","volume":"160","author":"J Theberge","year":"2003","journal-title":"Am J Psychiatry"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1023\/A:1026773005303","article-title":"Hyperprolinaemia in patients with deletion (22)(q11.2) syndrome.","volume":"23","author":"BK Goodman","year":"2000","journal-title":"J Inherit Metab Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/npp.2008.132","article-title":"Proline affects brain function in 22q11DS children with the low activity COMT 158 allele.","volume":"34","author":"JA Vorstman","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"ref32","first-page":"5","article-title":"The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.","volume":"64","author":"JM Kane","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia.","volume":"13","author":"SR Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.2044-8260.1986.tb00675.x","article-title":"Principal components of the WAIS-R.","volume":"25","author":"AGM Canavan","year":"1986","journal-title":"Br J Clin Psychology"},{"key":"ref35","article-title":"WAIS-III: Wechsler Adult Intelligence Scale. Administration and Scoring Manual","author":"D Wechsler","year":"1997"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mrm.1910300604","article-title":"Estimation of metabolite concentrations from localized in vivo proton NMR spectra.","volume":"30","author":"SW Provencher","year":"1993","journal-title":"Magn Reson Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.biopsych.2009.05.006","article-title":"Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume.","volume":"66","author":"JM Stone","year":"2009","journal-title":"Biol Psychiatry"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0925-4927(00)00044-5","article-title":"Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies.","volume":"98","author":"LS Kegeles","year":"2000","journal-title":"Psychiatry Res"},{"key":"ref39","article-title":"Proton MRS in twin pairs discordant for schizophrenia.","author":"ES Lutkenhoff","year":"2008","journal-title":"Mol Psychiatry."},{"key":"ref40","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.biopsych.2005.04.041","article-title":"Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study.","volume":"58","author":"LT Van Elst","year":"2005","journal-title":"Biol Psychiatry"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/15622970701227811","article-title":"Frontolimbic glutamate alterations in first episode schizophrenia: evidence from a magnetic resonance spectroscopy study.","volume":"9","author":"HM Olbrich","year":"2008","journal-title":"World J Biol Psychiatry"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.lfs.2007.09.031","article-title":"Proline promotes decrease in glutamate uptake in slices of cerebral cortex and hippocampus of rats.","volume":"81","author":"D Delwing","year":"2007","journal-title":"Life Sci"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1097\/00001756-200108080-00007","article-title":"(1)H-MR spectroscopy differentiates mild cognitive impairment from normal brain aging.","volume":"12","author":"M Catani","year":"2001","journal-title":"Neuroreport"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/WAD.0b013e3181875434","article-title":"Regional myo-inositol concentration in mild cognitive impairment Using 1H magnetic resonance spectroscopic imaging.","volume":"23","author":"M Siger","year":"2009","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/archpsyc.62.12.1360","article-title":"Hippocampal myo-inositol and cognitive ability in adults with Down syndrome: an in vivo proton magnetic resonance spectroscopy study.","volume":"62","author":"F Beacher","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/35073015","article-title":"Back in the water: the return of the inositol phosphates.","volume":"2","author":"RF Irvine","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1046\/j.1471-4159.2002.01041.x","article-title":"Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance.","volume":"82","author":"SK Fisher","year":"2002","journal-title":"J Neurochem"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1023\/A:1022397704922","article-title":"Role of astrocytes in the maintenance and modulation of glutamatergic and GABAergic neurotransmission.","volume":"28","author":"A Schousboe","year":"2003","journal-title":"Neurochem Res"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","article-title":"Glutamate uptake.","volume":"65","author":"NC Danbolt","year":"2001","journal-title":"Prog Neurobiol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.biopsych.2007.05.025","article-title":"Brain metabolite abnormalities in the white matter of elderly schizophrenic subjects: implication for glial dysfunction.","volume":"62","author":"L Chang","year":"2007","journal-title":"Biol Psychiatry"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.schres.2007.05.024","article-title":"Neurochemical and structural correlates of executive dysfunction in schizophrenia.","volume":"99","author":"N Rusch","year":"2008","journal-title":"Schizophr Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jpsychires.2006.07.002","article-title":"Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.","volume":"41","author":"P Ohrmann","year":"2007","journal-title":"J Psychiatr Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.schres.2008.11.014","article-title":"Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS).","volume":"108","author":"S Tayoshi","year":"2009","journal-title":"Schizophr Res"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/01.chi.0000205704.33077.4a","article-title":"Temporal lobe anatomy and psychiatric symptoms in velocardiofacial syndrome (22q11.2 deletion syndrome).","volume":"45","author":"WR Kates","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1176\/appi.ajp.158.3.447","article-title":"Velocardiofacial syndrome: are structural changes in the temporal and mesial temporal regions related to schizophrenia?","volume":"158","author":"S Eliez","year":"2001","journal-title":"Am J Psychiatry"},{"key":"ref56","article-title":"Hippocampal Glutamate Levels and Striatal Dopamine D(2\/3) Receptor Occupancy in Subjects at Ultra High Risk of Psychosis.","author":"OJ Bloemen","year":"2011","journal-title":"Biol Psychiatry."},{"key":"ref57","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.biopsych.2010.05.034","article-title":"Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosis.","volume":"68","author":"JM Stone","year":"2010","journal-title":"Biol Psychiatry"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1136\/bmj.316.7139.1236","article-title":"What's wrong with Bonferroni adjustments.","volume":"316","author":"TV Perneger","year":"1998","journal-title":"BMJ"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10571-006-9062-8","article-title":"Glutamate and schizophrenia: beyond the dopamine hypothesis.","volume":"26","author":"JT Coyle","year":"2006","journal-title":"Cell Mol Neurobiol"},{"key":"ref60","first-page":"282","article-title":"Using animal models to test a neurodevelopmental hypothesis of schizophrenia.","volume":"29","author":"BK Lipska","year":"2004","journal-title":"J Psychiatry Neurosci"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archgenpsychiatry.2009.24","article-title":"Widespread reductions of cortical thickness in schizophrenia and spectrum disorders and evidence of heritability.","volume":"66","author":"AL Goldman","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0006-3223(00)00997-5","article-title":"The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia.","volume":"49","author":"A Bertolino","year":"2001","journal-title":"Biol Psychiatry"}],"updated-by":[{"DOI":"10.1371\/annotation\/805ba3f5-0fd7-41f9-bc2c-31ebf507f05b","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2011,8,22]],"date-time":"2011-08-22T00:00:00Z","timestamp":1313971200000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0021685","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T00:26:23Z","timestamp":1539995183000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0021685"}},"subtitle":[],"editor":[{"given":"Takeo","family":"Yoshikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,6,30]]},"references-count":62,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,6,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0021685","relation":{"correction":[{"id-type":"doi","id":"10.1371\/annotation\/805ba3f5-0fd7-41f9-bc2c-31ebf507f05b","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,30]]}}}